Abstract

Objective: Among women of reproductive age most common complex endocrine disorder is polycystic ovarian syndrome (PCOS). The main objective of this retrospective study was to evaluate relative prevalence and symptomatology of PCOS among young girls.

Materials and Methods: This was an observational retrospective study conducted in a tertiary care clinic at Cuttack, Odisha. Patients clinical record were used to fetch the clinical data. For making clinical diagnosis of PCOS no universally accepted validated tool available. If all three elements of Rotterdam criteria were present, final diagnosis of PCOS was made.

Results: A total 350 young girl with mean age 17.4 ± 1.3 years were finally eligible for this retrospective analysis. 7 (2%) patients were presented with hirsutism only and 15 (4.29%) of patients presented with irregular menses or oligo or anovulation. Whereas 20 (5,71%) of patients were presented with both. Among other endocrinological abnormalities hair loss or alopecia and acne were found in 76 (21.71%) and in 287 (82%) respectively. 8.57% were the prevalence of PCOS among the young girls (Table 3). Presence of PCOS were strongly associated with waist hip ratio ≥ 0.85 (< 0.0001) and BMI ≥ 25 (P value < 0.0001) among all the risk factors. 4% subjects were aware of PCOS (health seeking behavior).

Conclusion: Among the adolescent and young girls, Polycystic ovary syndrome is fast attaining epidemic proportion, which is related to the increasing stress and sedentary lifestyle and increasing trends of metabolic syndrome. From this study, it is concluded that only 24% of girls were aware of PCOS and 8.57% were the prevalence of PCOS among the young girls. To prevent long term consequences of metabolic syndrome timely intervention and Identifying women for PCOs is necessary.

Keywords: Endocrinopathy; PCOS; Menstrual Irregularity; Rotterdam Criteria

References

1. Franks S. “Polycystic Ovary Syndrome”. The New England Journal of Medicine 333 (1995): 853-861.
2. Dunaif A. “Insulin resistance and Polycystic Overay Syndrome: mechanism and implication for pathogenesis”. Endocrine Reviews 18 (1997): 774-800.
3. Stein IF and Leventhal MI. “Amenorrhoea associated with bilateral polycystic ovaries”. The American Journal of Obstetrics and Gynecology 29 (1935): 181-191.
4. Stein IF. “Duration of infertility following ovarian wedge resection”. Western Journal of Nursing Research 72 (1964): 237.
5. Nidhi R., et al. “Prevalence of Polycystic Ovarian Syndrome in Indian Adolescents”. Journal of Pediatric and Adolescent Gynecology 4 (2011): 223-227.
6. Gupta M., et al. “A cross sectional study of polycystic ovarian syndrome among young women in Bhopal, Central India”. International Journal Of Community Medicine and Public Health 5 (2018): 95-100.
7. Vaidya R and Joshi B. “PCOS-epidemic in India: An emerging public health challenge”. International Conf PCOS Society India with AE-PCOS Society USA 19-6-2016 (2021).
8. Choudhary A., et al. “Prevalence and symptomatology of polycystic ovarian syndrome in Indian women: is there a rising incidence?” International Journal of Reproduction, Contraception, Obstetrics and Gynecology 6 (2017): 4971-4975.
9. Shetty D., et al. “Exercise in polycystic ovarian syndrome: An evidence-based review”. Saudi Journal of Sports Medicine3 (2017): 123-128.
10. Diamanti-Kandarakis E., et al. “A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile”. The Journal of Clinical Endocrinology and Metabolism 84 (1999): 4006-4011.
11. Knochenhauer ES., et al. “Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study”. The Journal of Clinical Endocrinology and Metabolism 83 (1998): 3078-3082.
12. Asuncion M., et al. “A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain”. The Journal of Clinical Endocrinology and Metabolism 85 (2000): 2434-2438.
13. March WA., et al. “The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria”. Human Reproduction 25 (2010): 544-551.
14. Lindholm A., et al. “Prevalence of symptoms associated with polycystic ovary syndrome”. International Journal of Gynecology and Obstetrics 102 (2008): 39-43.
15. Williamson K., et al. “The impact of ethnicity on the presentation of polycystic ovarian syndrome”. The Australian and New Zealand Journal of Obstetrics and Gynaecology 2 (2001): 202-206.
16. Lo J., et al. “Increased Prevalence of Gestational Diabetes Mellitus Among Women With Diagnosed Polycystic Ovary Syndrome: A population-based study”. Diabetes Care8 (2006): 1915-1917.
17. Saxena P., et al. “PCOS: is obesity a sine qua non? a clinical, hormonal and metabolic assessment in relation to BMI”. The Indian Journal of Endocrinology and Metabolism 6 (2012): 996-999.
18. Alvarez-Blasco F., et al. “Prevalence and Characteristics Of The Polycystic Ovary Syndrome In Overweight and Obese Women”. Archives of Internal Medicine 19 (2006): 2081-2086.
19. Sanchez N. “A life course perspective on polycystic ovary syndrome”. International Journal of Women's Health 6 (2014): 115-118.
20. Majumdar A and Singh TA. “Comparision of clinical features and health manifestations in Lean vs obese Indian women with polycystic ovarian syndrome”. Journal of Human Reproductive Sciences 2 (2009): 12-17.
21. Yildiz BO., et al. “Impact of Obesity on the Risk for Polycystic Ovary Syndrome”. The Journal of Clinical Endocrinology and Metabolism 1 (2008): 162-168.
22. Sunanda B and Nayak S. “A Study to Assess the Knowledge Regarding PCOS (Polycystic OvarianSyndrome) among Nursing Students at NUINS”. The Nitte University Journal of Health Science 3 (2016).
23. Sowmya MA and Fernandes P. “Effectiveness of structured teaching programme on knowledge of Polycystic Ovarian Syndrome among adolescent girls”. The Nitte University Journal of Health Science 3 (2016).
24. Amasha HA and Heeba MF. “Implementation and Evaluation of Effectiveness of Educating Program for Upgrading Nurses”. Knowledge Regarding Polycystic Ovaries Syndrome1 (2014): 1-8.